FDA Investigator Jeanne J Thai
Jeanne J Thai has inspections in 10 countries as of 15 Dec 2023. Jeanne J Thai has collaborated with a combinined 3429 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
144
Last Inspection Date:
15 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Chile,
Spain,
Malaysia,
Italy,
Israel,
Netherlands,
Canada
Co-Investigator(s):
Adam J Taylor,
Adam M True,
Alan M Barker,
Alan M Roberts,
Alanna Lmussawwir Bias,
Alicia M Mozzachio,
Alla Dubrovsky,
Amanda B Athey,
Amanda E Lewin, PhD,
Amanda S Zorn,
Amy Kim,
Ana L Kewes,
Anastasia I Onuorah,
Arindam Dasgupta, PhD,
Audrey Dela Cruz,
Barbara D Wright,
Barbara G Langer,
Bonnie E Conley,
Bonnie E Pierson,
Bradley J Maunder,
Brentley S Collins,
Brian D Nicholson,
Brian P Emanuel,
Bruce H Mccullough,
Bryan L Mcguckin,
Carl A Huffman, III,
Carolyn A Volpe,
CDR Rochelle B Young, RPh, MSA,
Charles A Snipes, PhD,
Chase S Baldwin,
Chery Grandinetti,
Christina A Miller,
Colleen E Burke,
Courtney N Long,
Craig A Garmendia,
Cynthia Jim, CSO,
Daniel B Bordt,
Dariusz Galezowski,
Darla J Christopher,
Dawn C Olenjack,
Debra Boyd Seale,
Debra I Love,
Debra L Boyd Seale,
Decarlos A Gomez,
Denarvis C Mendenhall,
Denise L Burosh,
Donna D Gallien, MPH,
Donna K Speer,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Elizabeth L Holmes,
Eric M Mueller, PharmD,
Eric S Pittman,
Erin M Mcdowell,
Erin Mcdowell,
Esther A Ofori,
Gabrielle J Swain,
Gene D Arcy,
Gloria A Milster,
Hanna L Potter,
Hasan A Irier, PhD,
Hoimay Chan,
Humera T Khan,
Irina Gaberman,
Ismael Olvera, IV,
James L Finn,
James P Duggan,
James W Plucinski,
Janae D Price,
Jasmine Y Wang,
Jeanne J Chiu,
Jeanne M Morris,
Jennifer A D'angelo,
Jennifer C Adams,
Jennifer C Johnson,
Jesse A Vazquez,
Jocelyn C Turner,
John A Iwen,
Jonathan R Campos,
Joseph A Piechocki,
Joshua M Adams,
Kara A Scheibner, PhD,
Karen Emasley Joseph,
Karen M Montgomery (KMM),
Kathleen A Schelble,
Kathleen S Tormey,
Kellia N Hicks,
Kenneth L Smalls,
Kimberly A Dutzek,
Kristin M Abaonza,
Kujtim Sadiku,
Lacey J Chessor,
Lacey J Rice,
Lan T Tran,
Lana K Waselewski,
Lance M De Souza, MBA,
Larry F Hallberg,
Latoya A Griffith,
Lauren A Crivellone,
Lauren N Howard,
Laurie A Haxel,
Lavender M Huskey,
Laverne Puckett,
Leeterry Moore,
Leighton K Ngai,
Lequita M Mayhew,
Leslie D Hintz,
Lewis K Antwi,
Li Hongpaul Yeh, PhD,
Linh Tu,
Lisa Hayka,
Lisa Haykay,
Lisa Hornback,
Lori A Gioia,
Lucila B Nwatu,
Lynda L Lanning,
M Anthonyabel I,
Makini Cobourne Duval, PhD,
Marcia A Worley,
Margaret Torres Vazquez,
Maria Diaz,
Mark C Saale,
Mark I Kaspar,
Matthew J Sienko,
Melkamu Getie Kebtie, PhD,
Michael D Robinson,
Michael P Anthony,
Michele L Glendenning,
Michele Perry Williams,
Myra K Casey,
Nancy A Bellamy,
Natasha R Johnson,
Nathan R Moon,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole C Victoria, PhD,
Nicole S Williams,
Pablo Alcantara,
Pankaj H Amin,
Patricia A Mcilroy,
Patrick E Gainer,
Paul M Chefor,
Paula P Demichael,
Peng Zhou,
Prajakta A Varadkar,
Rachel E Mcguigan,
Rafael Padilla,
Randy D Baxter,
Raymond W Brullo,
Robert J Ham,
Roberta W Cunningham,
Ronda R Loyd Jones,
Rosemary A Sexton,
Ruben C Ayala, PharmD,
Russell K Riley,
Ruth A Williams,
Samuel W Labinjo,
Sandra S Saniga,
Sarah Nwandiuko,
Scott B Laufenberg,
Shalonda C Clifford,
Sherri J Jackson,
Sripal R Mada, PhD,
State Agency,
Sullan,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Susan M North,
Susan W Ciani,
Susan Yuscius,
Tara A Marshall,
Tara C Alcazar,
Teena H Aiken,
Tenzin Jangchup,
Thea C Grome,
Theressa B Smith,
Thomas J Arista,
Thunder N Dunkijacobs,
Todd M Stankewicz,
Tong Zhou,
Travis S Bradley,
Uruaku A Obasi,
Vaishali J Patel,
Wayne W Grundstrom,
William F Lagud, Jr,
William R Weissinger,
William V Millar,
Yangmin Ning,
Yiyue Zhang (nmi), PhD,
Yuanyuan Li,
Zerita White
Jeanne J Thai's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more